#Incretin mimetics
GLP-1, GIP, glucagon receptor agonists.
How Incretin Drugs Affect the Heart
A new review finds heart benefits from incretin drugs like tirzepatide and retatrutide involve pathways beyond blood sugar control.
CT130: A GLP-1 Drug Built to Take Breaks
CT130 is a semaglutide-derived GLP-1 drug tested so far in mice and monkeys, not humans, built around scheduled drug-free intervals.
Why Dying Liver Cells Drive MASH
A 2026 review explains how cell death fuels MASH, the liver disease semaglutide became the first FDA-approved drug to treat.
Semaglutide and tirzepatide for MASH
Semaglutide now has FDA approval for MASH liver fibrosis, and tirzepatide's phase 2 data suggests a stronger signal is coming.
Incretin malnutrition review explained
A new review of tirzepatide, semaglutide and related trials raises nutrition questions without proving common clinical malnutrition.
T-BEAT Japan: design, not results
The T-BEAT paper describes a Japanese tirzepatide and oral semaglutide study, but reports baseline data rather than treatment outcomes.
STEP 12: semaglutide in Chinese adults
STEP 12 tested semaglutide 2.4 mg in Chinese adults at a BMI of 24 to under 30, a band the earlier STEP obesity trials never enrolled.
Tirzepatide cuts liver fat despite PNPLA3
A post hoc look at SURPASS-3 MRI finds tirzepatide cut liver fat in type 2 diabetes whether or not patients carried the PNPLA3 I148M gene variant.
Can peptides fix a slow metabolism?
A reader on r/peptides asked if peptides could fix years of unexplained weight gain. Here is what GLP-1 drugs actually do, and what to test first.
Can GLP-1 Drugs Help Ulcerative Colitis?
A matched cohort study links semaglutide and liraglutide use to higher ulcerative colitis remission, though neither drug is approved for IBD.
GLP-1 drugs and erectile dysfunction
A new meta-analysis links GLP-1 drugs like semaglutide and tirzepatide to modest erectile-function gains, though other research disagrees.
GLP-1 Drugs and Psoriasis Healthcare Use
A new JEADV letter examines whether GLP-1 and GLP-1/GIP drugs like tirzepatide and semaglutide change healthcare use in psoriasis patients.